These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials. Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381 [TBL] [Abstract][Full Text] [Related]
12. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Spyropoulos AC; Turpie AG; Dunn AS; Kaatz S; Douketis J; Jacobson A; Petersen H; Am J Cardiol; 2008 Oct; 102(7):883-9. PubMed ID: 18805116 [TBL] [Abstract][Full Text] [Related]
13. Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis. Lai KN; Ho K; Cheung RC; Lit LC; Lee SK; Fung KS; Tong MK; Lam CW Int J Artif Organs; 2001 Jul; 24(7):447-55. PubMed ID: 11510916 [TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis. Leu JG; Liou HH; Wu SC; Yang WC; Huang TP; Wu SC J Formos Med Assoc; 1998 Jan; 97(1):49-54. PubMed ID: 9481065 [TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism. Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504 [TBL] [Abstract][Full Text] [Related]
16. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing. Näsström B; Stegmayr B; Gupta J; Olivecrona G; Olivecrona T Nephrol Dial Transplant; 2005 Jun; 20(6):1172-9. PubMed ID: 15797889 [TBL] [Abstract][Full Text] [Related]
17. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
18. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins. Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239 [TBL] [Abstract][Full Text] [Related]
19. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism. Creekmore FM; Oderda GM; Pendleton RC; Brixner DI Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654 [TBL] [Abstract][Full Text] [Related]